This item is authorised by the following title:
To include a retrospective amendment made by the Therapeutic Goods (Excluded Goods) Amendment Determination (No. 2) 2024
Therapeutic Goods (Excluded Goods) Amendment Determination 2024 (F2024L00692)
Therapeutic Goods (Excluded Goods) Amendment (Vaping) Determination 2024 (F2024L00843)
Therapeutic Goods (Excluded Goods) Amendment Determination (No. 2) 2024 (F2024L00985)
Therapeutic Goods (Excluded Goods) Amendment (Sunscreen) Determination 2024 (F2024L00657)
Therapeutic Goods (Excluded Goods) Amendment (Vaping) Determination 2023 (F2023L01684)
Mitochondrial Donation Law Reform (Maeve’s Law) Act 2022 (C2022A00026)
Therapeutic Goods (Excluded Goods) Amendment (Personalised Medical Devices) Determination 2021 (F2021L01161)
Therapeutic Goods (Excluded Goods) Amendment (Borderline Products—COVID-19) Determination 2021 (F2021L01049)
Therapeutic Goods (Excluded Goods) Amendment (Software-based Products) Determination 2021 (F2021L00047)
Therapeutic Goods (Excluded Goods) Amendment (Vaping Devices) Determination 2021 (F2021L00112)
Therapeutic Goods Amendment (Excluded Goods) Determination (No. 1) 2020 (F2020L00464)
Therapeutic Goods Amendment (Excluded Goods) Determination (No. 2) 2019 (F2019L00985)
